Literature DB >> 18770049

Development of a melting tablet containing promethazine HCl against motion sickness.

Rahul V Haware1, P D Chaudhari, S R Parakh, A Bauer-Brandl.   

Abstract

The purpose of this study was to design a 'Traveller Friendly Drug Delivery System' for PM-HCl. Conventional promethazine (PM-HCl) tablets are bitter, need to be taken 1 h before symptoms and water is also needed. Taste-masked granules were produced with Eudragit E100 by extrusion, and analyzed with FTIR, DSC, and XRD. Tablets formulated from granules by direct compression using Ac-Di-Sol, Polyplasdone-XL, Primojel and ion-exchanger Tulsion339 and evaluated for mass uniformity, friability, tensile strength, drug content uniformity, water absorption ratio, in-vitro and in-vivo disintegration time and in-vitro dissolution studies. The observed drug-polymer interactions and reduced crystallinity may be reasons for increased dissolution rates. The formulated tablets were disintegrated within 15 s. Tablets (25 mg PM-HCl) with Ac-Di-Sol (4%) showed complete release within 1 min, while marketed conventional tablets (Phenergan; Rhone-Poulec) release 25% during the same period. A preliminary stability studies for the prepared tablets carried at 30 +/- 2 degrees C/60 +/- 5% RH, and 40 +/- 2 degrees C/75 +/- 5%RH for 3 months showed no significant changes in the tablets quality at 30 +/- 2 degrees C/60 +/- 5% RH. However, at 40 +/- 2 degrees C/75 +/- 5%RH marked increase in in-vitro disintegration time, tensile strength and decrease in friability and water absorption ratio was found. The present studies indicate the abilities of Eudragit E 100 for taste masking and improving the dissolution profile of PM-HCl after complexation. In addition, by employing cost effective direct compression method, fast-dissolving tablets of 400 mg total weight with an acceptable quality could be prepared.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18770049      PMCID: PMC2977014          DOI: 10.1208/s12249-008-9133-x

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  5 in total

1.  Regulatory aspects of stability testing in Europe.

Authors:  B R Matthews
Journal:  Drug Dev Ind Pharm       Date:  1999-07       Impact factor: 3.225

2.  Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.

Authors:  Y Bi; H Sunada; Y Yonezawa; K Danjo; A Otsuka; K Iida
Journal:  Chem Pharm Bull (Tokyo)       Date:  1996-11       Impact factor: 1.645

3.  Computer analysis of the relation between tablet strength and compaction pressure.

Authors:  J M Newton; G Rowley; J T Fell; D G Peacock; K Ridgway
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

4.  Evaluation of rapidly disintegrating tablets prepared by a direct compression method.

Authors:  Y X Bi; H Sunada; Y Yonezawa; K Danjo
Journal:  Drug Dev Ind Pharm       Date:  1999-05       Impact factor: 3.225

5.  Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method.

Authors:  T Ishikawa; Y Watanabe; N Utoguchi; M Matsumoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1999-10       Impact factor: 1.645

  5 in total
  3 in total

1.  Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approach.

Authors:  Parind Mahendrakumar Desai; Patrick Xuan Hua Er; Celine Valeria Liew; Paul Wan Sia Heng
Journal:  AAPS PharmSciTech       Date:  2014-05-22       Impact factor: 3.246

Review 2.  pH- and ion-sensitive polymers for drug delivery.

Authors:  Takayuki Yoshida; Tsz Chung Lai; Glen S Kwon; Kazuhiro Sako
Journal:  Expert Opin Drug Deliv       Date:  2013-08-09       Impact factor: 6.648

Review 3.  Motion sickness: an overview.

Authors:  Alexander Kc Leung; Kam Lun Hon
Journal:  Drugs Context       Date:  2019-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.